APA

Klein M., Schermuly R. T., Ellinghaus P., Milting H., Riedl B., Nikolova S., Pullamsetti S. S., Weissmann N., Dony E., Savai R., Ghofrani H. A., Grimminger F., Busch A. E. & Schäfer S. (20081202). Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling. : Circulation.

Chicago

Klein Martina, Schermuly Ralph T, Ellinghaus Peter, Milting Hendrik, Riedl Bernd, Nikolova Sevdalina, Pullamsetti Soni S, Weissmann Norbert, Dony Eva, Savai Rajkumar, Ghofrani Hossein A, Grimminger Friedrich, Busch Andreas E and Schäfer Stefan. 20081202. Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling. : Circulation.

Harvard

Klein M., Schermuly R. T., Ellinghaus P., Milting H., Riedl B., Nikolova S., Pullamsetti S. S., Weissmann N., Dony E., Savai R., Ghofrani H. A., Grimminger F., Busch A. E. and Schäfer S. (20081202). Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling. : Circulation.

MLA

Klein Martina, Schermuly Ralph T, Ellinghaus Peter, Milting Hendrik, Riedl Bernd, Nikolova Sevdalina, Pullamsetti Soni S, Weissmann Norbert, Dony Eva, Savai Rajkumar, Ghofrani Hossein A, Grimminger Friedrich, Busch Andreas E and Schäfer Stefan. Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling. : Circulation. 20081202.